Status:
NOT_YET_RECRUITING
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
Lead Sponsor:
University of Minnesota
Conditions:
Postpartum
Hypertension
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duratio...
Eligibility Criteria
Inclusion
- 18 years or older
- Discharged after delivery at University of Minnesota Medical Center
- Enrolled into the HOPE-BP Program
Exclusion
- Ongoing antihypertensive medication use at 2 weeks (time of randomization)
- Have a medical comorbidity that would not be clinically appropriate to randomize
- Patients opted out of clinical research
Key Trial Info
Start Date :
January 7 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07204756
Start Date
January 7 2026
End Date
January 31 2028
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455